IAVI

Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Scientific Publications

Clinic presentation delay and tuberculosis treatment outcomes in the Lake Victoria region of East Africa: A multi-site prospective cohort study

Read more

Scientific Publications

Proportion of Ugandans with pre-pandemic SARS-CoV-2 cross-reactive CD4+ and CD8+ T-cell responses: A pilot study

Read more

Scientific Publications

“I fear those things”: non-uptake of contraceptives, and barriers to use among adolescent girls and young women at high risk of HIV infection in Kampala, Uganda

Read more

Videos

IAVI Annual Report 2022

August 9, 2023

Throughout 2022, IAVI continued to forge new and build on existing partnerships with governments, academia, industry, and other scientific consortia globally that advance vaccine and antibody candidates from concept to clinic. Our socio-behavioral research and global access initiatives support product development that is rooted in and informed by the realities of communities where disease burden is the greatest. Together with our network of clinical research center partners in Africa and India, we conducted clinical trials, strengthened in-country research capacity, and supported the training and education of the next generation of scientists and advocates. Read the full 2022 Annual Report here: bit.ly/IAVI_Annual_Report_2022

Read more

Scientific Publications

Turning the Gaze from Survive to Thrive for Children in India: Learnings from Two Case Studies

Read more

Scientific Publications

Africa-specific human genetic variation near CHD1L associates with HIV-1 load

Read more

Features

Discovery of gene limiting replication of HIV published in Nature

August 2, 2023

New study of nearly 4,000 people of African ancestries led to identification of gene inhibiting HIV replication.

Read more

ADVANCE

ADVANCE (Accelerate the Development of Vaccines and New Technologies to Combat the AIDS Epidemic) is a 5-year cooperative agreement extended through June 2026 with the U.S. Agency for International Development (USAID), through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR).

Read more